Banerjee B, Kanitpong K, Fink J N, Zussman M, Sussman G L, Kelly K J, Kurup V P
Department of Pediatrics, Allergy-Immunology Division, Medical College of Wisconsin, Milwaukee, WI, USA.
Mol Immunol. 2000 Aug-Sep;37(12-13):789-98. doi: 10.1016/s0161-5890(00)00095-x.
Of the several latex proteins cloned and expressed, the rubber elongation factor, Hev b 1, and the closely related Hev b 3, represent two major allergens associated with latex allergy. Although both allergens demonstrated IgE binding with sera from latex allergic patients, it was not known whether these two molecules shared any epitopes. Hence, in the present study using health care workers (HCW) and spina bifida (SB) patients with latex allergy, we investigated the IgE binding epitopes in Hev b 1 and Hev b 3. Recombinant Hev b 1 and Hev b 3 were expressed in a prokaryotic expression system, while overlapping decapeptides of Hev b 1 and Hev b 3 were synthesized on derivatized cellulose membrane. Eight IgE binding epitopes for Hev b 1 and eleven for Hev b 3 were identified using sera from latex allergic patients with SB. On further analysis of synthetic peptides encompassing these epitopes, similar IgE antibody reactivity was demonstrated with three Hev b 1 epitopes b1E3, b1E5, b1E6 and two Hev b 3 epitopes; b3E10 and b3E 11. For Hev b 1, a unique IgE binding epitope was identified in the region of amino acid residues 16-25. In competitive ELISA, peptides bIE2 and bIE4 together inhibited 58% of IgE binding of Hev b 1, while b3E5 showed 22% inhibition in the IgE binding of Hev b 3. The results of the present study suggest that the understanding of linear and conformational IgE epitopes in the major latex allergens may provide better insight into the structure-function relationship of the allergens, and may lead to the development of better patient care and management strategies in latex allergy.
在已克隆和表达的几种乳胶蛋白中,橡胶延长因子Hev b 1以及与之密切相关的Hev b 3,是与乳胶过敏相关的两种主要过敏原。尽管这两种过敏原都能与乳胶过敏患者的血清发生IgE结合,但尚不清楚这两种分子是否共享任何表位。因此,在本研究中,我们以医护人员(HCW)和患有乳胶过敏的脊柱裂(SB)患者为研究对象,对Hev b 1和Hev b 3中的IgE结合表位进行了研究。重组Hev b 1和Hev b 3在原核表达系统中表达,而Hev b 1和Hev b 3的重叠十肽则在衍生化纤维素膜上合成。使用患有SB的乳胶过敏患者的血清,鉴定出了8个Hev b 1的IgE结合表位和11个Hev b 3的IgE结合表位。对包含这些表位的合成肽进行进一步分析发现,三个Hev b 1表位b1E3、b1E5、b1E6和两个Hev b 3表位b3E10和b3E 11表现出相似的IgE抗体反应性。对于Hev b 1,在氨基酸残基16 - 25区域鉴定出一个独特的IgE结合表位。在竞争性ELISA中,肽bIE2和bIE4共同抑制了58%的Hev b 1的IgE结合,而b3E5对Hev b 3的IgE结合显示出22%的抑制作用。本研究结果表明,了解主要乳胶过敏原中的线性和构象性IgE表位,可能有助于更好地洞察过敏原的结构 - 功能关系,并可能有助于制定更好的乳胶过敏患者护理和管理策略。